The ENT devices market will touch USD 31,805.3 million, growing at a 6.9% during compound annual growth rate, by 2030. This growth is because of the mounting occurrence of sinusitis and hearing disorders, rising healthcare expenses, and increasing fondness for minimally invasive processes in the ENT field. 

Moreover, the surging elderly populace also boosts the need for ENT devices, because the elderly populace is more disposed to hearing loss as well as disorders related to nose and throat.The diagnostic devices category, on the basis of product type, led the industry in the past few years. This is because of the accessibility of various products, the arrival of new companies, the increasing occurrence of different ENT disorders, and the mounting aging populace. Furthermore, the introduction of novel products will further boost the expansion of this category. 

Whereas, the hearing aids category accounted for the second-largest share, in the past few years. Moreover, this category will advance at the fastest rate, of 7.6%, in the years to come. This category growth is primarily because of the increasing acceptance of these systems, technology incorporation in hearing aids, and the rising funding in research and development activities. 

The hospitals category, on the basis of end user, was the largest contributor to the ENT devices market, in the past few years. This can be mainly because of the increasing disposable salary and the enhanced healthcare spending & infrastructure. Moreover, the category is also boosted by the rising awareness and knowledge regarding ENT procedures globally, coupled with the declining price of ENT treatment. 

Whereas, the ENT clinics category will propel at the fastest rate in the years to come. This will be primarily because this clinic offers treatment services for ENT ailments at a lower price, with the use of developed technology products for diagnostic, treatment, or screening. 

North America accounted for the largest share of the industry in recent years. This is mainly because of the enhanced reimbursement scenario for ENT measures and the existence of major companies in this continent.  Additionally, the increasing consciousness regarding the usefulness of ENT devices resulted in the enlarged adoption of these devices in this continent. 

APAC will propel at the fastest rate during this decade, where India and China are major countries in this region. This will be mainly because of the existence of a large patient pool suffering from sinusitis, the increase in the aging populace, and the surge in consciousness of these devices. 

It is because of the rise in the prevalence of hearing disorders and sinusitis, the ENT devices industry will continue to advance in the years to come. 

SOURCE: P&S Intelligence